Effects of belimumab on peripheral blood Breg cells and cytokines in childhood systemic lupus erythematosus
{{output}}
To evaluate the therapeutic effectiveness of belimumab (BLM) in childhood systemic lupus erythematosus (cSLE) by analyzing peripheral blood Breg cell subsets and related cytokines at multiple time points post-treatment, compared with conventional therapy. From... ...
